Antibodies from patients infected with SARS-CoV in 2003 cross-neutralised SARS-CoV-2 in vitro: Study

Must read

How to disable and delete Samsung Pay from your Galaxy phone

When it comes to paying conveniently, Samsung Pay makes using your phone as a bank card an easy process; however, there may come...

How to Find Your Spotify Wrapped 2020

2020 has been a year for the books, but that hasn’t stopped anyone from streaming and listening to countless hours of music on...

Mi Robot Vacuum Mop-P Shipments in India Delayed, Xiaomi Now Promises to Ship by December 1

Mi Robot Vacuum Mop-P shipments in India have been delayed until December 1. The robotic vacuum cleaner was launched in the country...
Bhawani Singh
I am a blogger who believes in delivering latest tech news from around the world to my viewers.

WASHINGTON: Antibodies in serum samples collected from patients infected with SARS-CoV during the 2003 outbreak effectively neutralised SARS-CoV-2 infection in cultured cells, according to a new study.
The study was published in the journal –Science Advances.
The authors also report that, surprisingly, mice and rabbits immunised with a receptor-binding domain (RBD) from a strain of SARS-CoV that infects the Himalayan palm civet elicited stronger antibody responses against SARS-CoV-2 than animals immunised with an RBD from a human SARS-CoV strain.
The authors suggest that their findings may inform strategies to develop universal vaccines against emerging and future coronaviruses. Yuanmei Zhu and colleagues analyzed 20 convalescent serum samples from patients infected with SARS-CoV, determining cross-reactivity for protein antigens derived from four regions of the SARS-CoV-2 spike protein, including the S ectodomain (S), S1 subunit, RBD, and S2 subunit. While all serum samples reacted strongly with the S and S2 proteins, they reacted more weakly with the S1 and RBD proteins. A separate test using a single-cycle infection assay determined that the convalescent SARS-CoV sera efficiently prevented both SARS-CoV and SARS-CoV-2 pseudoviruses (which cannot produce viral surface proteins on their own) from infecting cells, although they inhibited SARS-CoV-2 activity less efficiently.
The researchers verified their findings in animals and specifically characterized the RBD’s ability to mediate cross-reactivity in mice since the RBD is the least conserved of the spike protein sites between the two viruses. They found that anti-RBD serum from SARS-CoV cross-reacted well with SARS-CoV-2, suggesting a key antigen component is genetically conserved in the RBD sites of the two viruses.
Zhu et al. note that although antibody-dependent enhancement (when binding a virus to certain antibodies actually eases its entry into host cells) was not observed in this study, the effect should be addressed during vaccine development.

Source link

More articles

Leave a Reply

Subscribe to our newsletter

To be updated with all the latest news, offers and special announcements.

- Advertisement -

Latest article

ZTE Blade V2021 5G With Triple Rear Cameras, Dimensity 720 SoC Launched: Price, Specifications

ZTE Blade V2021 5G has been launched in China as the latest smartphone offering from the company. The phone has a triple rear...

How to view your Spotify 2020 Wrapped top songs, artists, and more

Spotify has launched 2020 Wrapped to summarize the year on Android and iOS.This year includes quizzes, Stories, badges and new playlists.It explores podcasts,...

Spotify 2020 Wrapped Offers Insights on Your Listening Habits for the Year

Spotify 2020 Wrapped is live for eligible users and offers a look at their listening habits of the past 11 months. It is...

Kangana Ranaut blocks Himanshi Khurana on Twitter, ‘wohh, krta block’ says ex-Bigg Boss contestant – bollywood

Former Bigg Boss contestant Himanshi Khurana has been blocked on Twitter by Kangana Ranaut, after she criticised her comments on the ongoing farmer...

Oscars 2021 Will Be An ‘In-Person Telecast’ And Not A Virtual One, Confirms Academy

Earlier today, Britain gave the whole world good news after it became the first country in the world to approve a...
- Advertisement -